by: TN Media News Pakistan: The 5th International Neuroscience Summit for the Middle East, Africa, and Russia (MEANS) commenced in Dubai, bringing together a distinguished group of global and regional experts in neurology. Held in collaboration with AbbVie, the global biopharmaceutical company, the summit features top-tier physicians, consultants, researchers, and representatives from medical associations across the Gulf, Egypt, Russia, and beyond.
The event includes scientific sessions on recent research and treatment innovations for neurological disorders such as Parkinson’s disease, migraine, and post-stroke spasticity.
Dr. Abdulrazzaq Al-Bilali, Head of the Saudi Headache Chapter, emphasized the vital role of research in advancing neurology and noted progress in headache diagnosis and management. Dr. Suhail Al Rukun, President of the Emirates Neurology Society, highlighted the summit’s role in promoting medical dialogue and sharing the latest clinical practices to improve patient outcomes.
Mohammad Aboubakr, AbbVie’s regional Vice President, reaffirmed the company’s commitment to supporting scientific education and enhancing the quality of healthcare through innovative research and training initiatives.
